Выбор редакции

Allergan's belkyra will be first prescription 'double chin' treatment licensed in Europe

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.